These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 9018696)

  • 1. In vitro activity of fluconazole on Candida albicans.
    Abecia LC; Arévalo JM; López MJ
    Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole].
    Yücesoy M; Marol S
    Mikrobiyol Bul; 2002; 36(3-4):317-22. PubMed ID: 12838666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of fluconazole against Candida albicans isolated from blood culture].
    Pemán J; Cantón E; Orero A; Ubeda P; Viudes A; Pastor A; Gobernado M
    Rev Esp Quimioter; 1998 Dec; 11(4):339-43. PubMed ID: 10336314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
    Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
    J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulatory effect of cAMP on fungal ergosterol level and inhibitory activity of azole drugs.
    Sardari S; Mori Y; Kurosawa T; Daneshtalab M
    Can J Microbiol; 2003 May; 49(5):344-9. PubMed ID: 12897828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the in vitro activity of fluconazole against Candida albicans and dermatophytes.
    Wildfeuer A; Seidl HP
    Arzneimittelforschung; 1995 Jul; 45(7):819-21. PubMed ID: 8573230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening of Candida albicans fluconazole--resistant mutation strains].
    Wang W; Zhang B; Wang X; Liu Y; Wang D
    Wei Sheng Wu Xue Bao; 1997 Jun; 37(3):212-6. PubMed ID: 9863212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chemosensitizers on minimum inhibitory concentrations of fluconazole in Candida albicans.
    Bulatova NR; Darwish RM
    Med Princ Pract; 2008; 17(2):117-21. PubMed ID: 18287794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
    Mondello F; De Bernardis F; Girolamo A; Salvatore G; Cassone A
    J Antimicrob Chemother; 2003 May; 51(5):1223-9. PubMed ID: 12668571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of several species of Candida and Torulopsis to fluconazole and ketoconazole.
    Mallié M; Montès B; Reynes J; Bastide JM
    Drugs Exp Clin Res; 1990; 16(10):509-13. PubMed ID: 2100733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans.
    Navarro-Martínez MD; García-Cánovas F; Rodríguez-López JN
    J Antimicrob Chemother; 2006 Jun; 57(6):1083-92. PubMed ID: 16585130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alternative oxidase of Candida albicans causes reduced fluconazole susceptibility.
    Yan L; Li M; Cao Y; Gao P; Cao Y; Wang Y; Jiang Y
    J Antimicrob Chemother; 2009 Oct; 64(4):764-73. PubMed ID: 19656781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
    Sanati H; Belanger P; Fratti R; Ghannoum M
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal mechanisms supporting boric acid therapy of Candida vaginitis.
    De Seta F; Schmidt M; Vu B; Essmann M; Larsen B
    J Antimicrob Chemother; 2009 Feb; 63(2):325-36. PubMed ID: 19059942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
    Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
    Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.
    Lamfon H; Porter SR; McCullough M; Pratten J
    J Antimicrob Chemother; 2004 Feb; 53(2):383-5. PubMed ID: 14729749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication?
    Ribeiro MA; Paula CR
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):71-5. PubMed ID: 16839736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans.
    Arai R; Sugita T; Nishikawa A
    Mycoses; 2005 Jan; 48(1):38-41. PubMed ID: 15679664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.